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A lthough a substantial number of patients undergovalvular operations in the United States each year
(>200,000 since 1990), there is no validated approach
for routine evaluation of possible obstructive coronary
artery disease (CAD) in this population. Current
American College of Cardiology/American Heart
Association practice guidelines for presurgical coronary
angiography include the following: male patients 35
years of age or older; female patients who are post-
menopausal or premenopausal and 35 years of age or
older with coronary risk factors; and patients with chest
pain, objective evidence of ischemia, one or more risk
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mitral valve degeneration and to demonstrate its potential clinical utility.
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history of myocardial infarction, ischemic electrocardiographic changes,
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angiography.
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age, male sex, hypertension, diabetes mellitus,and hyperlipidemia. Two hun-
dred twenty patients were designated as low risk according to the logistic
model. Of these patients, only 3 (1.3%) had single-vessel disease, and none
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area under the receiver-operating characteristic curve of 0.84. Cost analysis
indicated that application of this model could safely eliminate 30% of coro-
nary angiograms, corresponding to cost savings of $430,000 per 1000
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factors for CAD, previous CAD, or decreased left ven-
tricular systolic function.1 Considering that the estimat-
ed mean ages of patients who underwent mitral and
aortic valve operations in the United States between
1990 and 1996 were 64 and 68 years of age, respec-
tively,2 with more than half of 31,000 patients undergo-
ing mitral valve operations not requiring concurrent
coronary artery bypass grafting, these guidelines rec-
ommend coronary angiography for the vast majority
who ultimately will not undergo revascularization.
Although coronary angiography is generally a low-risk
procedure, a validated model for preoperative coronary
angiography may be helpful by eliminating the cost and
morbidity of unnecessary studies.
The present study was undertaken to (1) construct
and validate a model to estimate the risk of obstructive
CAD on the basis of clinical predictors in a large series
of patients undergoing operations for degenerative
mitral valve disease, (2) propose an algorithm for coro-
nary angiography before the operations in these
patients, and (3) compare the use of this algorithm with
current practice guidelines.
Methods
Patient selection. We identified 1178 consecutive patients
from the Cleveland Clinic Foundation Cardiovascular
Information Registry3 who underwent operations for degen-
erative mitral valve disease (998 myocardial mitral valve
repairs and 180 replacements) between 1989 and 1996. This
prospectively collected and validated database provides com-
prehensive descriptions of clinical and surgical characteristics
of all patients undergoing cardiac operations at the institution
since 1971. One hundred three patients who did not undergo
coronary angiography at the discretion of the attending staff
cardiologist were excluded. In addition, 353 patients with
previous myocardial infarction (n = 158), ischemic electro-
cardiographic changes (n = 99), angina (n = 195), or some
combination thereof were excluded from analysis because
these patients clearly were reasonable candidates for preoper-
ative coronary angiography. Thus, 722 patients were included
in our study.
Clinical data. Angina was limited strictly to symptoms
with at least two of the following characteristics: (1) subster-
nal chest discomfort with characteristic quality and duration
that is (2) provoked by exertion or emotional stress and (3)
relieved by rest or nitroglycerin.4 Ischemic electrocardio-
graphic changes were strictly defined as the presence of diag-
nostic Q waves or abnormal baseline ST segment changes of
0.1 mV or greater consistent with ischemia unrelated to meta-
bolic abnormalities, drug effects, conduction disturbances, or
ventricular hypertrophy. Previous myocardial infarction was
defined by means of clinical history, diagnostic Q waves, or
thinned akinetic segments on resting echocardiography.
Risk factor selection. Established CAD risk factors,
including age, sex, diabetes mellitus, smoking, family history
of CAD, hypertension, and hyperlipidemia, were recorded
systematically according to standard definitions elucidated in
detail elsewhere.5 In addition, abnormal left ventricular func-
tion defined as an ejection fraction of 50% or less by means
of echocardiography or contrast ventriculography and New
York Heart Association class III or IV were also designated a
priori for analyses. The presence of obstructive CAD was
defined as 50% or greater luminal narrowing in one or more
major epicardial vessels by means of coronary angiography.
Statistical analysis
Model development and validation. All designated clinical
variables were initially entered into univariable analyses.
Predictors of obstructive CAD in the univariable analyses
were entered into a forward stepwise multivariable logistic
regression model.6 All variables except age were analyzed
categorically. Only independent predictors (P < .05) were
included in the multivariable model:
Model score (Ln OR) = α + x1β1 + x2β2 + x3β3 + x4β4
+ ...... + xkβk
in which Ln OR is the natural logarithm of the odds ratio; α
is a constant; x1,...., and xk are independent predictors; andβ1,...., and βk represent respective parameter coefficients. A
model score based on the sum of parameter coefficient vari-
able products and the α term in the model was calculated to
identify patients with 5% or lower predicted risk of CAD. On
the basis of the regression equation, the odds ratio is related
to risk of obstructive CAD by the following equation:
Risk of CAD = eOR/(eOR + 1)
A model score of 2.95 corresponds to approximately 5%
risk of CAD. This subgroup is defined as having a low risk of
CAD.
The multivariable logistic model was validated and further
refined by using the bootstrap technique.7 By using this com-
puter-intensive approach, 1000 random resamplings and
respective multivariable analyses were performed to assess
the stability of odds ratio estimates with sampling variation.
The bootstrap-validated 95% confidence interval was defined
by the lower 2.5 and upper 97.5 percentile values and was
compared with original logistic model estimates.
Model validity was examined by assessing model dis-
crimination and precision. Discrimination reflects the
model’s ability to distinguish patients with CAD from
those without CAD. Receiver-operating characteristic
curves were used to compare discrimination of the original
and bootstrap models.7,8 Precision refers to how closely
predicted fit observed outcomes; this was assessed by com-
paring the predicted versus observed prevalence of CAD
according to deciles of predicted risk and quantified by the
Hosmer-Lemeslow goodness-of-fit statistic, the coefficient
of determination (r3) with the Spearman rank correlation,
and the Brier score.
Comparison with current practice guidelines.  Use of the
bootstrap model was compared with class I indications from
current American College of Cardiology/American Heart
Association Practice Guidelines for the Management of
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Patients with Valvular Heart Disease.1 Cost analysis was per-
formed on the basis of 1998 Medicare reimbursement of out-
patient coronary angiography ($1424) for the Cleveland area.
Cost per patient with obstructive CAD identified was calcu-
lated for each strategy relative to the study population.
Continuous variables are expressed as mean values ± SD.
Categoric variables are expressed as frequencies, percentage,
or both. All statistical analyses were performed with SAS
6.12 software (SAS Inc, Cary, NC).
Results
Clinical characteristics. Clinical characteristics of
the study population are summarized in Table I. One
hundred thirty-nine (19%) patients in the study popula-
tion had obstructive CAD. Sex-specific prevalence of
CAD relative to the unadjusted age in the study cohort
is summarized in Fig 1. Both prevalence curves
increased in a curvilinear fashion with age, although
there was delayed onset of CAD of greater than 10
years in female patients. Of note, the prevalence of
obstructive CAD in both male patients 35 years of age
or female patients of perimenopausal age range was
extremely low.
Of 103 patients (47 men; age, 36 ± 12 years) in the
exclusion subset (n = 456) who did not undergo coro-
nary angiography, diabetes mellitus was present in 6,
hypertension in 11, hyperlipidemia in 21, family histo-
ry in 8, and smoking history in 23. None had more than
one established risk factor. Two hundred twenty-one
(61%) of 353 patients in the high-risk exclusion subset
with ischemic electrocardiographic changes, angina, or
previous myocardial infarction had obstructive CAD.
Model development and validation. Table II shows
the univariable association between obstructive CAD
and the prespecified factors evaluated as potential pre-
dictors. All variables, except for abnormal left ventric-
ular function, functional class, and family history, were
predictors in univariable analyses. Male sex, age, dia-
betes mellitus, hyperlipidemia, and hypertension were
also predictors in the logistic multivariable analysis and
further validated as predictive in the bootstrap validat-
ed model as follows:
Model score (Ln OR) = (0.105 × Age) + (1.177 
× Male sex) + (1.475 × Diabetes mellitus) + (1.750 
× Hyperlipidemia) + (0.483 × Hypertension) – 10.070.
Comparisons between bootstrap and estimated con-
fidence intervals are shown in Table III. There was a
strong similarity between the odds ratios of the orig-
inal and the bootstrap model, supporting the validity
of the model. On the basis of the bootstrap model
scores, 220 patients were designated as having a low
predicted risk for obstructive CAD (≤5%; model
scores, <–2.95). Of these patients, only 3 (1.3%) had
single-vessel disease, and none had high-risk CAD
(ie, left main trunk, proximal left anterior descend-
ing, or multivessel disease). Ninety percent stenosis
Fig 1. Sex-specific correlation of unadjusted age versus the
prevalence of CAD in 772 patients who underwent coronary
angiography before operations for degenerative mitral valve
disease.
Table I. Clinical characteristics of the study 
population
Study population 
Variable (n = 722)
Age (y) 61 ± 12
Male (%) 484 (67.0)
Diabetes mellitus (%) 32 (4.4)
Hypertension (%) 179 (24.8)
Hyperlipidemia (%) 237 (32.8)
Smoking (%) 87 (12.0)
Family history of CAD (%) 166 (23.0)
NYHA class
I or II (%) 598 (82.8)
III or IV (%) 124 (17.2)
Abnormal LV function* 232 (32.1)
Concurrent AV operation (%) 41 (5.6)
Concurrent TV operation (%) 45 (6.2)
CAD (%) 139 (19.3)
CABG (%) 128 (17.7)
Continuous variables are given as means ± SD. Categoric variables are given
as frequency (%). NYHA, New York Heart Association; LV, left ventricular; AV,
aortic valve; TV, tricuspid valve; CABG, coronary artery bypass grafting.
*Abnormal left ventricular function defined as an ejection fraction of 50% or
less.
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of the mid-left anterior descending artery was present
in one patient (46-year-old man), 70% stenosis of the
midcircumflex artery was present in another patient
(57-year-old man), and 50% stenosis of the distal cir-
cumflex artery was present in the third patient (38-
year-old man). None had established risk factors for
CAD. Obstructive CAD was present in 136 (27%) of
the 502 patients in the intermediate and high-risk
groups (>5%; model scores, ≥–2.95).
Model discrimination was examined by constructing
receiver-operating characteristic curves for the original
and bootstrap models in Fig 2. Areas under the curves
were nearly identical, being approximately 0.84 for
both models. Validation of the bootstrap model accord-
ing to deciles of predicted CAD risk is shown in Fig 3.
There was excellent agreement between observed and
predicted prevalences of disease across the predicted
risk, with no evidence of systematic overestimation or
underestimation. The Hosmer-Lemeshow statistic was
1.9 (P = .98). The coefficient of determination (r3)
between the predicted and observed prevalence was
0.99 (P < .001). The mean Brier score was quite low at
0.11, the median was 0.014, and the 25th to 75th per-
centiles were 0.002 and 0.11.
Comparisons between current practice guidelines
and the bootstrap model. In this study population, if
coronary angiography would have been performed in
all patients, the calculated cost per case of CAD identi-
fied would be $104,427 (220 × $1,424 ÷ 3) in the low-
risk group and $5256 per case of CAD (502 × $1,424 ÷
136) among those with intermediate or high-risk pro-
files. The proposed algorithm based on the logistic
model for presurgical coronary angiography is shown
in Fig 4. Application of this model could safely elimi-
nate 30.5% of coronary angiograms, with a high nega-
tive predictive value of 98.7%. This corresponds to a
cost saving of $433,906 per 1000 patients. Under cur-
rent American College of Cardiology/American Heart
Association practice guidelines, 97.9% should undergo
coronary angiography. No patient with obstructive
CAD would be missed, but the specificity and positive
predictive value of this approach were only 2.6% and
19.7%, respectively.
Comparing the cost difference between the 2 strate-
gies on the basis of the number of catheterizations rec-
ommended divided by the total cases of CAD identified
with each approach, there is a cost saving of $1990 per
case of CAD identified with the logistic model. Cost
analyses, rates of coronary angiography, and accuracy
for both strategies are summarized in Table IV.
Discussion
Our study is the first to develop a validated model
that shows that patients with surgical mitral regurgita-
tion caused by myxomatous disease who are at low risk
of obstructive CAD can be easily identified on the basis
of routine clinical information gathered during preop-
erative evaluation. The ability of our model to discrim-
inate patients with CAD from those without CAD is
demonstrated by the almost identical high areas (0.84)
under the receiver-operating characteristic curves
derived from the original and bootstrap models. The
high coefficient of determination (r3 = 0.99, P < .001)
between the predicted and observed prevalence of
CAD (Fig 3), along with the low Brier score, validate
the predictive value of the model.
Several previous studies have developed purely clin-
ical models to predict the risk of obstructive angio-
Fig 2. Receiver-operating characteristic (ROC) curves from
the original and the bootstrap models.
Table II. Univariable association between obstructive
coronary artery disease and prespecified categoric
factors
Variable OR 95% CI χ2 P value
Age* 2.58 2.06-3.23 68 <.0001
Male sex 2.02 1.31-3.11 10.08 <.005
Diabetes mellitus 5.28 2.74-10.17 24.68 <.005
Hypertension 1.88 1.29-2.72 10.91 <.005
Hyperlipidemia 4.22 2.88-6.20 54.02 <.005
Smoking 1.02 0.84-1.21 1.89 .169
Family history of CAD 1.17 0.80-1.73 0.64 .424
NYHA class III or IV 1.77 1.14-2.76 6.42 .011
Abnormal LV function 1.39 0.95-2.04 2.83 .092
OR, Odds ratio; CI, confidence interval; NYHA, New York Heart Association;
LV, left ventricular.
*Per 10-year increase.
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graphic CAD in symptomatic patients with chest
pain.9-14 Diamond and Forrester13 proposed a rule to
predict CAD on the basis of age, sex, and nature of
chest pain. Subsequently, Pryor and associates10 devel-
oped and validated a model based on established risk
factor profiles, chest pain characteristics, and electro-
cardiographic criteria. Application of these models to
patients with degenerative mitral valve disease may be
constrained by differences in baseline characteristics.
Patients with typical or atypical angina were excluded
from this analysis, whereas previous studies consisted
primarily of patients who presented for evaluation of
chest pain. The prevalence of CAD in previous models
ranged between 60% and 83%,8,9,11-13 which was
roughly 3 to 4 times that found in our study. The
strength of prediction and respective relationships
between predictors derived in previous analyses may
be lost in a population with a lower prevalence and
lesser severity of CAD.
Predictors of CAD in patients undergoing opera-
tions for degenerative mitral valve disease. Previous
surgical series have suggested that age of 40 years or
greater was a reliable predictor of CAD in patients
undergoing valve operations.15,16 Chest pain has also
been reported as a predictor in several studies.15,17-21 In
this low-prevalence cohort free of clinical and electro-
cardiographic evidence of CAD, the risk for obstructive
CAD was above low levels (>5%) beyond 56 and 68
years of age for male and female patients, respectively,
independent of other predictors. Likewise, family his-
tory and smoking were not predictive, although other
commonly recognized risk factors, including male sex,
hyperlipidemia, hypertension, and diabetes mellitus,
remained predictive in the bootstrap model.
Revascularization of CAD during valvular oper-
ations. Whether a selective catheterization approach
based on risk stratification adversely affects surgical
outcome is unclear. Although the presence of coexist-
ing CAD has been clearly linked to a worse prognosis
in patients undergoing valvular operations,22-25 the
incremental benefit from concurrent revascularization
in patients with nonsurgical disease is not defini-
tive.22,26,27 Although the current practice is to revas-
cularize coexisting CAD in these patients, random-
ized trials in nonvalve populations have revealed that
only patients with multivessel CAD in the presence of
proximal left anterior descending artery disease, left
ventricular dysfunction, or left main trunk disease
derived survival benefit from surgical revasculariza-
tion.28-30 In addition, revascularization of flow-limit-
ing CAD may not prevent myocardial infarction.
Angiographic studies have documented that plaque
composition and morphology, rather than severity of
luminal narrowing, are the major determinants of sub-
sequent acute coronary syndromes.31-33 Alternatively,
coronary bypass of non-flow-limiting lesions may
lead to accelerated venous bypass graft closure34 or
proximal native vessel atherosclerosis.35 Finally,
despite advances in surgical techniques and myocar-
dial protection,36,37 combined myocardial revascular-
ization and valvular operations are still associated
with a higher operative mortality compared with iso-
lated valvular operations.2
Comparisons between current guidelines and the
model. Although both strategies maintained relatively
high negative predictive values for the prediction of
CAD, an approach with greater discrimination and cost
reduction is an attractive alternative. Application of the
derived model would have eliminated nearly one third
of 722 angiographic studies, without missing any
patients with high-risk CAD. The accuracy was more
than 2-fold higher with this approach versus that with
existing guidelines, which corresponded to a substan-
tial cost reduction approaching 25% on the basis of
conservative measures of cost.
Limitations. This model was developed and vali-
dated in patients undergoing operations for degener-
ative mitral valve disease. For that reason, the size of
our study group was limited, and the observed preva-
lence of obstructive coronary artery disease was low.
Although its findings are potentially applicable to
those of other valvular populations, given the vari-
Table III. Multivariable predictors of obstructive CAD: Odds ratios and confidence intervals from original 
regression model estimates and the bootstrap model
Variable* Original model, OR (95% CI) Wald χ2 P value Bootstrap model, OR (95% CI)
Hyperlipidemia 5.51 (3.48-8.72) 53 <.0001 5.75 (3.45-9.14)
Diabetes mellitus 3.67 (1.44-9.37) 7 .007 4.37 (1.55-10.12)
Male sex 3.10 (1.87-5.15) 19 <.0001 3.24 (1.94-5.28)
Hypertension 1.56 (1.01-2.46) 4 .05 1.62 (0.98-2.47)
Age (10 y) 2.81 (2.18-3.62) 64 <.0001 2.81 (2.18-3.62)
OR, Odds ratio; CI, confidence interval.
*Smoking and family history were not predictors in the multivariable model.
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ability of baseline characteristics among different
valvular lesions, extrapolation should be avoided
until further validation. Patients in our study who
underwent concomitant tricuspid valve operations,
aortic valve operations, or both were few and had
these listed as secondary conditions. Similar results
were obtained, however, when we repeated analysis
after excluding those patients. Second, our definition
of low risk is arbitrary and not universally accepted.
We arrived at a cutoff value of less than 5% on the
Fig 3. Comparison of the observed versus predicted prevalence of CAD according to deciles of predicted risk. r3,
Coefficient of determination. Range of probabilities: decile 1, 0.0001-0.014; decile 2, 0.014-0.029; decile 3, 0.029-
0.049; decile 4, 0.050-0.074; decile 5, 0.075-0.108; decile 6, 0.108-0.163; decile 7, 0.165-0.229; decile 8, 0.231-
0.334; decile 9, 0.343-0.508; and decile 10, 0.525-0.901.
Fig 4.  Proposed algorithm to risk stratify patients undergoing operations for degenerative mitral valve disease
operations. MI, Myocardial infarction; ECG, electrocardiogram.
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basis of (1) optimal positive and negative predictive
values calculated for cutoffs of 1%, 5%, and 10% and
(2) minimal acceptance level agreed on by a group of
practicing cardiologists and cardiothoracic surgeons.
Nevertheless, by using this cutoff point, not even one
patient with high-risk CAD (ie, left main trunk, prox-
imal left anterior descending, or multivessel disease)
was missed. Furthermore, the bootstrap validated
model allows the clinician to quantify the risk of
obstructive CAD by using routine information gath-
ered preoperatively and recommend coronary
angiography on the basis of individual definition of
low risk. Nevertheless, further validation of our
model in an independent patient population is war-
ranted before recommending its widespread adoption
in the clinical practice. Finally, despite the substan-
tial reduction in the number of low-yield angiograph-
ic studies, there is still a sizeable cohort with inter-
mediate risk who may benefit from additional
noninvasive risk stratification (ie, exercise echocar-
diography). Future studies are required to explore
this issue.
Conclusions
A model based on routine clinical predictors gathered
preoperatively provided reliable estimates of CAD risk
in patients undergoing degenerative mitral valve dis-
ease operations. Considering the increasing constraint
on health care resources, an evidence-based approach
of using coronary angiography for patients who have
an intermediate or high likelihood of CAD is an attrac-
tive and rational alternative. Greater diagnostic yield at
a lower cost was achieved with the derived model than
with current practice guidelines. Future large-scale
prospective studies are required to confirm these results
and determine their applicability to other types of non-
ischemic surgical heart disease.
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operations.
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